磺胺脲类药物在肾小球战场。

Q2 Medicine European Endocrinology Pub Date : 2018-09-01 Epub Date: 2018-09-10 DOI:10.17925/EE.2018.14.2.15
Sanjay Kalra, Deepak Khandelwal, Sarita Bajaj, Ashok Kumar Das
{"title":"磺胺脲类药物在肾小球战场。","authors":"Sanjay Kalra,&nbsp;Deepak Khandelwal,&nbsp;Sarita Bajaj,&nbsp;Ashok Kumar Das","doi":"10.17925/EE.2018.14.2.15","DOIUrl":null,"url":null,"abstract":"<p><p>The kidney is important in the context of diabetes not only because it is involved in normal glucose homeostasis, but also because it is one of the most important end organs to be involved in diabetes complications. Glomeruli are the meeting point of both microvascular, or renal; and macrovascular, or cardiovascular, health in diabetes. Sulfonylureas are effective glucose-lowering drugs. While a sulfonylurea-based glucose-lowering strategy is nephro-safe and nephro-protective, this aspect of sulfonylurea pharmaco-biology has not been highlighted earlier. In this editorial, we discuss current preclinical and clinical trial evidence regarding the performance of modern sulfonylureas at the glomerular battlefield.</p>","PeriodicalId":38860,"journal":{"name":"European Endocrinology","volume":"14 2","pages":"15-17"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.17925/EE.2018.14.2.15","citationCount":"1","resultStr":"{\"title\":\"Sulfonylureas at the Glomerular Battlefield.\",\"authors\":\"Sanjay Kalra,&nbsp;Deepak Khandelwal,&nbsp;Sarita Bajaj,&nbsp;Ashok Kumar Das\",\"doi\":\"10.17925/EE.2018.14.2.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The kidney is important in the context of diabetes not only because it is involved in normal glucose homeostasis, but also because it is one of the most important end organs to be involved in diabetes complications. Glomeruli are the meeting point of both microvascular, or renal; and macrovascular, or cardiovascular, health in diabetes. Sulfonylureas are effective glucose-lowering drugs. While a sulfonylurea-based glucose-lowering strategy is nephro-safe and nephro-protective, this aspect of sulfonylurea pharmaco-biology has not been highlighted earlier. In this editorial, we discuss current preclinical and clinical trial evidence regarding the performance of modern sulfonylureas at the glomerular battlefield.</p>\",\"PeriodicalId\":38860,\"journal\":{\"name\":\"European Endocrinology\",\"volume\":\"14 2\",\"pages\":\"15-17\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.17925/EE.2018.14.2.15\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/EE.2018.14.2.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/9/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/EE.2018.14.2.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/9/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

肾脏在糖尿病中很重要,不仅因为它参与正常的葡萄糖稳态,而且因为它是参与糖尿病并发症的最重要的终末器官之一。肾小球是微血管或肾的交汇点;糖尿病的大血管或心血管健康。磺脲类药物是有效的降糖药物。虽然以磺脲类药物为基础的降糖策略对肾脏安全且具有保护作用,但磺脲类药物生物学的这方面尚未得到重视。在这篇社论中,我们讨论了目前关于现代磺脲类药物在肾小球战场上的表现的临床前和临床试验证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sulfonylureas at the Glomerular Battlefield.

The kidney is important in the context of diabetes not only because it is involved in normal glucose homeostasis, but also because it is one of the most important end organs to be involved in diabetes complications. Glomeruli are the meeting point of both microvascular, or renal; and macrovascular, or cardiovascular, health in diabetes. Sulfonylureas are effective glucose-lowering drugs. While a sulfonylurea-based glucose-lowering strategy is nephro-safe and nephro-protective, this aspect of sulfonylurea pharmaco-biology has not been highlighted earlier. In this editorial, we discuss current preclinical and clinical trial evidence regarding the performance of modern sulfonylureas at the glomerular battlefield.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Endocrinology
European Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
期刊最新文献
ADA-EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective. Clinical Profile and Factors Associated with Adverse Outcomes in Coronavirus Disease 2019-associated Mucormycosis: A Single-centre Study. What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review. Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the Horizon. Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1